TNF-alpha, produced by feline infectious peritonitis virus (FIPV)-infected macrophages, upregulates expression of type II FIPV receptor feline aminopeptidase N in feline macrophages
- PMID: 17382365
- PMCID: PMC7103289
- DOI: 10.1016/j.virol.2007.02.006
TNF-alpha, produced by feline infectious peritonitis virus (FIPV)-infected macrophages, upregulates expression of type II FIPV receptor feline aminopeptidase N in feline macrophages
Abstract
The pathogenicity of feline infectious peritonitis virus (FIPV) is known to depend on macrophage tropism, and this macrophage infection is enhanced by mediation via anti-S antibody (antibody-dependent enhancement, ADE). In this study, we found that TNF-alpha production was increased with viral replication in macrophages inoculated with a mixture of FIPV and anti-S antibody, and demonstrated that this culture supernatant had feline PBMC apoptosis-inducing activity. We also demonstrated that the expression level of the FIPV virus receptor, feline aminopeptidase N (fAPN), was increased in macrophages of FIP cats. For upregulation of TNF-alpha and fAPN in macrophages, viral replication in macrophages is necessary, and their expressions were increased by ADE of FIPV infection. It was demonstrated that a heat-resistant fAPN-inducing factor was present in the culture supernatant of FIPV-infected macrophages, and this factor was TNF-alpha: fAPN expression was upregulated in recombinant feline TNF-alpha-treated macrophages, and FIPV infectivity was increased in these macrophages. These findings suggested that FIPV replication in macrophages increases TNF-alpha production in macrophages, and the produced TNF-alpha acts and upregulates fAPN expression, increasing FIPV sensitivity.
Figures








Similar articles
-
Analysis of the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection: aminopeptidase N is not important and a process of acidification of the endosome is necessary.J Gen Virol. 2008 Apr;89(Pt 4):1025-1029. doi: 10.1099/vir.0.83558-0. J Gen Virol. 2008. PMID: 18343845
-
Intriguing interplay between feline infectious peritonitis virus and its receptors during entry in primary feline monocytes.Virus Res. 2011 Sep;160(1-2):32-9. doi: 10.1016/j.virusres.2011.04.031. Epub 2011 May 12. Virus Res. 2011. PMID: 21600938 Free PMC article.
-
Feline aminopeptidase N serves as a receptor for feline, canine, porcine, and human coronaviruses in serogroup I.J Virol. 1996 Dec;70(12):8669-74. doi: 10.1128/JVI.70.12.8669-8674.1996. J Virol. 1996. PMID: 8970993 Free PMC article.
-
Feline Coronaviruses: Pathogenesis of Feline Infectious Peritonitis.Adv Virus Res. 2016;96:193-218. doi: 10.1016/bs.aivir.2016.08.002. Epub 2016 Aug 31. Adv Virus Res. 2016. PMID: 27712624 Free PMC article. Review.
-
Feline infectious peritonitis: still an enigma?Vet Pathol. 2014 Mar;51(2):505-26. doi: 10.1177/0300985814522077. Vet Pathol. 2014. PMID: 24569616 Review.
Cited by
-
Efficient influenza A virus replication in the respiratory tract requires signals from TLR7 and RIG-I.Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13910-5. doi: 10.1073/pnas.1303275110. Epub 2013 Aug 5. Proc Natl Acad Sci U S A. 2013. PMID: 23918369 Free PMC article.
-
Vascular endothelial growth factor (VEGF), produced by feline infectious peritonitis (FIP) virus-infected monocytes and macrophages, induces vascular permeability and effusion in cats with FIP.Virus Res. 2011 Jun;158(1-2):161-8. doi: 10.1016/j.virusres.2011.03.027. Epub 2011 Apr 5. Virus Res. 2011. PMID: 21473893 Free PMC article.
-
Effect of chloroquine on feline infectious peritonitis virus infection in vitro and in vivo.Antiviral Res. 2013 Aug;99(2):100-7. doi: 10.1016/j.antiviral.2013.04.016. Epub 2013 May 3. Antiviral Res. 2013. PMID: 23648708 Free PMC article.
-
Curing Cats with Feline Infectious Peritonitis with an Oral Multi-Component Drug Containing GS-441524.Viruses. 2021 Nov 5;13(11):2228. doi: 10.3390/v13112228. Viruses. 2021. PMID: 34835034 Free PMC article.
-
B-cell activation in cats with feline infectious peritonitis (FIP) by FIP-virus-induced B-cell differentiation/survival factors.Arch Virol. 2009;154(1):27-35. doi: 10.1007/s00705-008-0265-9. Epub 2008 Nov 30. Arch Virol. 2009. PMID: 19043660 Free PMC article.
References
-
- Atrasheuskaya A., Petzelbauer P., Fredeking T.M., Ignatyev G. Anti-TNF antibody treatment reduces mortality in experimental dengue virus infection. FEMS Immunol. Med. Microbiol. 2003;35:33–42. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous